U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Health Economics & Outcomes Research Senior Expert - Rare Disease, UK

Biology & BiotechUpdated on Nov 14
Full-timeNo salary listed

About the Job

Requirements

  • A Master's degree or PhD in Health Economics, Outcomes Research, Market Access, Public Health, Epidemiology, Pharmacy, or a related discipline is required.
  • Strong experience within Health Economics and Outcomes Research, Market Access, Outcomes Research, or Health Economics in the pharmaceutical, biotechnology, or consulting sectors is required.
  • Expertise in health economic modelling, cost-effectiveness analyses, budget impact modelling, and outcomes research methodologies is required.
  • Experience supporting health technology assessment submissions, reimbursement processes, and payer evidence requirements across multiple markets is required.
  • Experience working across regions or at a global or intercontinental level, with a strong understanding of diverse healthcare systems and payer environments, is required.

Responsibilities

  • Support the development and execution of global health economics and outcomes research and payer evidence strategies aligned with asset and market access objectives.
  • Design and deliver health economics and outcomes research studies and deliverables, including cost-effectiveness models, budget impact models, systematic literature reviews, indirect treatment comparisons, healthcare resource utilization studies, and health-related quality-of-life research.
  • Develop asset value assessments and economic value frameworks to support pricing, reimbursement, and access decisions.
  • Shape and communicate economic value stories for assigned assets and indications.
  • Influence clinical development programs to ensure evidence generation plans address health technology assessment and payer requirements, including evolving European Union health technology assessment needs.
  • Contribute to global value dossiers and support affiliate teams in developing market access and reimbursement strategies.
  • Partner with cross-functional teams to deliver evidence-generation initiatives such as patient preference studies, natural history studies, and other outcomes research programs.
  • Provide health economics and outcomes research expertise and guidance throughout the product lifecycle, translating evidence into access outcomes.
  • Contribute to scientific publications, congress presentations, abstracts, posters, and external scientific engagement activities.
  • Share best practices, methodologies, and emerging approaches across the health economics and outcomes research community to support innovation and continuous improvement.

Desired Qualifications

  • Experience in Rare Disease is highly desirable.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs